JAGX
Price
$2.41
Change
+$0.09 (+3.88%)
Updated
Jul 21 closing price
Capitalization
3.19M
RNAZ
Price
$9.49
Change
-$0.20 (-2.06%)
Updated
Jul 22, 10:30 AM (EDT)
Capitalization
8.08M
Interact to see
Advertisement

JAGX vs RNAZ

Header iconJAGX vs RNAZ Comparison
Open Charts JAGX vs RNAZBanner chart's image
Jaguar Health
Price$2.41
Change+$0.09 (+3.88%)
Volume$165.65K
Capitalization3.19M
TransCode Therapeutics
Price$9.49
Change-$0.20 (-2.06%)
VolumeN/A
Capitalization8.08M
JAGX vs RNAZ Comparison Chart in %
Loading...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAGX vs. RNAZ commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Hold and RNAZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (JAGX: $2.41 vs. RNAZ: $9.69)
Brand notoriety: JAGX and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 157% vs. RNAZ: 25%
Market capitalization -- JAGX: $3.19M vs. RNAZ: $8.08M
JAGX [@Biotechnology] is valued at $3.19M. RNAZ’s [@Biotechnology] market capitalization is $8.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 1 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • JAGX’s FA Score: 1 green, 4 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, both JAGX and RNAZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 4 TA indicator(s) are bullish while RNAZ’s TA Score has 5 bullish TA indicator(s).

  • JAGX’s TA Score: 4 bullish, 2 bearish.
  • RNAZ’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both JAGX and RNAZ are a good buy in the short-term.

Price Growth

JAGX (@Biotechnology) experienced а +0.84% price change this week, while RNAZ (@Biotechnology) price change was +6.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.58%. For the same industry, the average monthly price growth was +17.57%, and the average quarterly price growth was +33.81%.

Industries' Descriptions

@Biotechnology (+5.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAZ($8.08M) has a higher market cap than JAGX($3.19M). JAGX has higher P/E ratio than RNAZ: JAGX (0.01) vs RNAZ (0.00). RNAZ (-89.731) and JAGX (-90.455) have similar YTD gains . RNAZ has higher annual earnings (EBITDA): -25.05M vs. JAGX (-37.39M). RNAZ has more cash in the bank: 11.6M vs. JAGX (5.69M). RNAZ has less debt than JAGX: RNAZ (0) vs JAGX (38.3M). JAGX has higher revenues than RNAZ: JAGX (11.6M) vs RNAZ (0).
JAGXRNAZJAGX / RNAZ
Capitalization3.19M8.08M40%
EBITDA-37.39M-25.05M149%
Gain YTD-90.455-89.731101%
P/E Ratio0.010.00773%
Revenue11.6M0-
Total Cash5.69M11.6M49%
Total Debt38.3M0-
FUNDAMENTALS RATINGS
JAGX: Fundamental Ratings
JAGX
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAGXRNAZ
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNEY2.620.10
+3.85%
CN Energy Group Inc
VRNT21.600.79
+3.80%
Verint Systems
PAG166.421.39
+0.84%
Penske Automotive Group
ORC7.06N/A
N/A
Orchid Island Capital
IMPP3.12-0.09
-2.80%
Imperial Petroleum

JAGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAGX has been closely correlated with WINT. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if JAGX jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
+3.88%
WINT - JAGX
90%
Closely correlated
-16.81%
CDTX - JAGX
90%
Closely correlated
-4.85%
NCNA - JAGX
89%
Closely correlated
+6.92%
TAOX - JAGX
89%
Closely correlated
-8.90%
RNAC - JAGX
89%
Closely correlated
+1.77%
More

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
-2.52%
NGNE - RNAZ
48%
Loosely correlated
-3.04%
MGNX - RNAZ
35%
Loosely correlated
-4.55%
BPTSY - RNAZ
33%
Poorly correlated
N/A
JAGX - RNAZ
31%
Poorly correlated
+3.88%
DVHGF - RNAZ
25%
Poorly correlated
N/A
More